BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7991944)

  • 1. Hyper-IgM syndrome.
    Di Santo JP; de Saint Basile G; Durandy A; Fischer A
    Res Immunol; 1994; 145(3):205-9; discussion 244-9. PubMed ID: 7991944
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation.
    Durandy A
    Biochem Soc Trans; 2002 Aug; 30(4):815-8. PubMed ID: 12196205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).
    Ramesh N; Fuleihan R; Geha R
    Immunol Rev; 1994 Apr; 138():87-104. PubMed ID: 7520884
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrinsic defect in B cells of patients with hyper-immunoglobulin M syndrome.
    Porat YB; Levy D; Levy J; Zan-Bar I
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):412-6. PubMed ID: 7583916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological reconstitution by allogeneic bone marrow transplantation in a child with the X-linked hyper-IgM syndrome.
    Kawai S; Sasahara Y; Minegishi M; Tsuchiya S; Fujie H; Ohashi Y; Kumaki S; Konno T
    Eur J Pediatr; 1999 May; 158(5):394-7. PubMed ID: 10333122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper IgM syndrome: two mutations distinguish HIM.
    Foy TM; Masters SR; Noelle RJ
    J Clin Invest; 1994 Oct; 94(4):1349-50. PubMed ID: 7523448
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand.
    Ameratunga R; McKee J; French J; Prestidge R; Fanslow W; Marbrook J
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):722-6. PubMed ID: 8914765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper IgM syndrome: the other side of the coin.
    Fuleihan RL
    Curr Opin Pediatr; 2001 Dec; 13(6):528-32. PubMed ID: 11753101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand/CD40 deficiency.
    Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
    Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
    Bhushan A; Barnhart B; Shone S; Song C; Covey LR
    J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
    Agematsu K; Nagumo H; Shinozaki K; Hokibara S; Yasui K; Terada K; Kawamura N; Toba T; Nonoyama S; Ochs HD; Komiyama A
    J Clin Invest; 1998 Aug; 102(4):853-60. PubMed ID: 9710455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two children with severe recurrent infections and the X-linked hyper-IgM syndrome].
    Groeneweg M; Hartwig NG; Poerink-Stockschläder AB; Schweizer JJ; Bijleveld CM; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1024-8. PubMed ID: 12811975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper IgM syndromes.
    Gulino AV; Notarangelo LD
    Curr Opin Rheumatol; 2003 Jul; 15(4):422-9. PubMed ID: 12819470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Life threatening pneumocystis carinii pneumonia in a 4-month-old boy with hyper-IgM syndrome].
    Heiming R; Beuschausen T; Liebner T; Seidenberg J; Roesler J
    Monatsschr Kinderheilkd; 1993 Nov; 141(11):860-3. PubMed ID: 8283991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity in a family with a CD40 ligand intracellular domain mutation.
    Kiani-Alikhan S; Yong PF; Gilmour KC; Grosse-Kreul D; Davies EG; Ibrahim MA
    J Clin Immunol; 2012 Feb; 32(1):70-7. PubMed ID: 22009004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
    Groeneweg M; Lankester AC; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1).
    Ramesh N; Morio T; Fuleihan R; Worm M; Horner A; Tsitsikov E; Castigli E; Geha RS
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S208-13. PubMed ID: 7554470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.
    Uronen H; Callard RE
    Clin Exp Immunol; 2000 Aug; 121(2):346-52. PubMed ID: 10931152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
    Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
    J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.